Reunion: ARS and Public Health France launches an investigation into the exhibition at Chikungunya after the recent epidemic

Therefore,

Reunion: ars public health france:

This new study, which will start on August 25 for a period of three months, will consist in looking for chikungunya antibodies in the Reunional population, through the search for antibodies in the blood of almost 1,500 people, without distinction of age or sex, distributed in a balanced manner in the four districts of the island. Therefore,

« Whether or not there is a known history of Chikungunya, each participation is essential: the higher the number of participants, the more precise and representative the results of the level of collective immunity “, Specified SPF.

It will measure the proportion of people who have been infected, to document the current level of population immunity, to estimate the extent of the 2025 epidemic, to refine the analysis of the risk of epidemic for the coming years and reunion: ars public health france to better anticipate the risk of resurgence in the coming years. The results will also be used to adapt prevention strategies, strengthen epidemiological surveillance and optimize anti -optoral control actions.

Participants will be recruited in 23 partner medical biology biology laboratories, during blood samples taken within the framework of prescribed exams. After the initial analyzes, the remaining serum will be used, if the quantity allows, to seek the presence of antibodies. These tests will be carried out by the National Reference Center for Arbovirus. based in the CHU de la Réunion. Each patient included will receive the result of his analysis and thus know their immune status against Chikungunya.

The private laboratories of the island and the CHU de la Réunion actively participate in the implementation of this survey, in particular by informing the public and accompanying patients on the sample sites.

Generally benign, chikungunya causes a brutal reunion: ars public health france fever accompanied by intense muscle and joint pain. But complications-neurological, muscular, cardiovascular-, even deaths, can occur, and symptoms may persist beyond three months.

The World Health Organization (WHO) called on urgent action in July to avoid major epidemics from Chikungunya and that history is not repeated as 20 years ago, where almost half a million people had been affected.

Damien Chaillot

Reunion: ars public health france

Further reading: To learn all about the condition of your liverHaving a “young” brain allows you to live longerNew blood donation contraindicationsAs the VRS season approaches, the Federation of Women Doctors of Canada militates in favor of national measures to protect infants from the countryScientists have discovered a new symptom of Alzheimer’s disease that appears at night: a neurologist confirms it.

Comments (0)
Add Comment